BioDuro
BioDuro and CTI Biotechnology in preclinical drug development partnership
May 21, 2026Research and Development BioDuro, CTI Biotechnology
BioDuro has announced a strategic partnership with CTI Biotechnology. The collaboration will leverage the complementary strengths of both companies across critical stages …
BioDuro establishes joint manufacturing venture with Cenra
March 6, 2026Manufacturing and Production BioDuro, Cenra API Solutions, manufacturing
BioDuro, a Contract Research, Development and Manufacturing Organisation (CRDMO), has established a joint venture with Cenra API Solutions, also known …
Christopher Conway joins BioDuro board to strengthen global leadership
August 21, 2025Contract Manufacturing, Manufacturing and Production Bio X Cell, BioDuro, Corporate, board of directors, contract research development and manufacturing organisation
BioDuro has announced the appointment of Christopher Conway, CEO of Bio X Cell, to its board of directors, effective immediately. …
BioDuro and Atombeat partner to accelerate AI-powered peptide drug discovery
July 31, 2025Mergers and Acquisitions AI, BioDuro, Corporate, Devices
BioDuro and Atombeat have announced a partnership to launch an artificial intelligence (AI)-driven platform designed to accelerate peptide drug discovery …
BioDuro and Silicogenix collaborate to advance non-traditional drug development
June 11, 2025Manufacturing Services, Manufacturing and Production, Research and Development BioDuro, Oncology, Pharmacy, Silicogenix, contract research, contract research development and manufacturing organisation (CRDMO), drug development
BioDuro, a contract research, development and manufacturing organisation, has announced a strategic partnership with small molecule design specialist Silicogenix (SGX) …
Latest content
NIHR chief scientific adviser visits Huddersfield health innovation campus
One in three UK women with migraine say symptoms taken less seriously
Report highlights scope to expand day surgery
Sygnature formalises drug discovery collaboration with X-Chem
Codis appoints Steven Facer as chief commercial officer
